Robert Alexander Ingram, Director at Black Diamond Therapeutics, Inc. (BDTX), bought 5,000 shares at $30.46 ($152K) on 2020-09-30, disclosed to the SEC on 2020-10-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| NOVN | BUY | 2018-10-01 | $142K | — | Filing → |
| NOVN | BUY | 2017-08-29 | $55K | — | Filing → |
| CLSD | BUY | 2016-06-07 | $750K | — | Filing → |